These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8883711)
1. Early massive accumulation of In-111 pentetreotide in a metastatic liver tumor of islet cell carcinoma. Tsukamoto E; Kanegae K; Itoh K; Okushiba S; Ohno K; Katoh H; Tamaki N Ann Nucl Med; 1996 Aug; 10(3):339-42. PubMed ID: 8883711 [TBL] [Abstract][Full Text] [Related]
2. Octreotide-sensitive ectopic ACTH production by islet cell carcinoma with multiple liver metastases. Doi M; Imai T; Shichiri M; Tateno T; Fukai N; Ozawa N; Sato R; Teramoto K; Hirata Y Endocr J; 2003 Apr; 50(2):135-43. PubMed ID: 12803233 [TBL] [Abstract][Full Text] [Related]
3. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063 [TBL] [Abstract][Full Text] [Related]
4. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177 [TBL] [Abstract][Full Text] [Related]
5. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors. Nauck C; Ivancević V; Emrich D; Creutzfeldt W Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760 [TBL] [Abstract][Full Text] [Related]
6. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids. Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229 [TBL] [Abstract][Full Text] [Related]
7. Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors. Usmani S; Khan HA; Abdulla M; Ahmed N; abu Huda F; Marafi F; al Kandari F; al Mohannadi S; al Nafisi N Med Princ Pract; 2011; 20(4):356-61. PubMed ID: 21576997 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide. Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135 [TBL] [Abstract][Full Text] [Related]
9. [111In-pentetreotide in the study of tumors expressing somatostatin receptors]. Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660 [TBL] [Abstract][Full Text] [Related]
10. Whole body and tomographic scan with 111In-pentetreotide: preliminary data. Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769 [TBL] [Abstract][Full Text] [Related]
12. Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors. Ichijo T; Ishikawa M; Shimojo M; Tsubuku M; Tsuboi K; Miyachi Y J Hepatobiliary Pancreat Surg; 2001; 8(5):473-8. PubMed ID: 11702259 [TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma]. Behr T; Becker W; Koch W; Grebmeier J; Wolf F Z Gastroenterol; 1994 Feb; 32(2):100-4. PubMed ID: 7513113 [TBL] [Abstract][Full Text] [Related]